Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$108.35
At close: May 20 EDT
$110.00
1.651.52%
Pre-Market: 8:38 AM EDT
Comments
Loading...
Axsome Therapeutics Analyst Ratings and Price Targets | NASDAQ:AXSM | Benzinga
Axsome Therapeutics Inc has a consensus price target of $162 based on the ratings of 18 analysts. The high is $216 issued by Mizuho on March 27, 2025. The low is $105 issued by UBS on August 6, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Wells Fargo, and Baird on May 7, 2025, May 6, 2025, and May 6, 2025, respectively. With an average price target of $169 between HC Wainwright & Co., Wells Fargo, and Baird, there's an implied 53.64% upside for Axsome Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Wells Fargo
Baird
RBC Capital
Jefferies
1calculated from analyst ratings
Analyst Ratings for Axsome Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/07/2025 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $200 → $180 | Maintains | Buy | Get Alert |
| 05/06/2025 | Buy Now | 50% | Wells Fargo | Cerena Chen30% | $160 → $165 | Maintains | Overweight | Get Alert |
| 05/06/2025 | Buy Now | 47.27% | Baird | Joel Beatty66% | $160 → $162 | Maintains | Outperform | Get Alert |
| 04/29/2025 | Buy Now | 75.45% | RBC Capital | Leonid Timashev37% | $190 → $193 | Maintains | Outperform | Get Alert |
| 04/07/2025 | Buy Now | 81.82% | Jefferies | Andrew Tsai25% | → $200 | Initiates | → Buy | Get Alert |
| 04/03/2025 | Buy Now | 81.82% | HC Wainwright & Co. | Raghuram Selvaraju42% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 39.09% | Needham | Ami Fadia55% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2025 | Buy Now | 96.36% | Mizuho | Graig Suvannavejh51% | $212 → $216 | Maintains | Outperform | Get Alert |
| 03/06/2025 | Buy Now | 81.82% | HC Wainwright & Co. | Raghuram Selvaraju42% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | 39.09% | Needham | Ami Fadia55% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | 45.45% | Baird | Joel Beatty66% | $132 → $160 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | 72.73% | Morgan Stanley | Vikram Purohit37% | $125 → $190 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | 92.73% | Mizuho | Graig Suvannavejh51% | $195 → $212 | Maintains | Outperform | Get Alert |
| 02/25/2025 | Buy Now | 81.82% | HC Wainwright & Co. | Raghuram Selvaraju42% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 39.09% | Needham | Ami Fadia55% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | 81.82% | HC Wainwright & Co. | Raghuram Selvaraju42% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | 81.82% | Truist Securities | Joon Lee76% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | 74.55% | RBC Capital | Leonid Timashev37% | $143 → $192 | Maintains | Outperform | Get Alert |
| 02/19/2025 | Buy Now | 39.09% | Cantor Fitzgerald | Charles Duncan68% | $153 → $153 | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | 39.09% | Needham | Ami Fadia55% | $133 → $153 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 45.45% | Wells Fargo | Cerena Chen30% | $140 → $160 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | 60% | Deutsche Bank | David Hoang39% | → $176 | Initiates | → Buy | Get Alert |
| 02/11/2025 | Buy Now | 51.82% | B of A Securities | Jason Gerberry59% | $143 → $167 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 77.27% | Mizuho | Graig Suvannavejh51% | $137 → $195 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 72.73% | HC Wainwright & Co. | Raghuram Selvaraju42% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | Buy Now | 36.36% | Leerink Partners | Marc Goodman72% | $110 → $150 | Maintains | Outperform | Get Alert |
| 02/10/2025 | Buy Now | 20.91% | Needham | Ami Fadia55% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 02/03/2025 | Buy Now | 24.55% | Mizuho | Graig Suvannavejh51% | $122 → $137 | Maintains | Outperform | Get Alert |
| 02/03/2025 | Buy Now | 72.73% | Truist Securities | Joon Lee76% | $180 → $190 | Maintains | Buy | Get Alert |
| 02/03/2025 | Buy Now | 30% | RBC Capital | Brian Abrahams48% | $139 → $143 | Maintains | Outperform | Get Alert |
| 01/31/2025 | Buy Now | 72.73% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $190 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | 26.36% | RBC Capital | Brian Abrahams48% | $139 → $139 | Maintains | Outperform | Get Alert |
| 01/21/2025 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 20.91% | Needham | Ami Fadia55% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 63.64% | Truist Securities | Joon Lee76% | $150 → $180 | Maintains | Buy | Get Alert |
| 01/06/2025 | Buy Now | 20.91% | Needham | Ami Fadia55% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 12/31/2024 | Buy Now | 10.91% | Mizuho | Graig Suvannavejh51% | $124 → $122 | Maintains | Outperform | Get Alert |
| 12/31/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju42% | — | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | 18.18% | Needham | Ami Fadia55% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | 10% | Cantor Fitzgerald | Charles Duncan68% | $121 → $121 | Reiterates | Overweight → Overweight | Get Alert |
| 11/27/2024 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 5.45% | Baird | Joel Beatty66% | $112 → $116 | Maintains | Outperform | Get Alert |
| 11/13/2024 | Buy Now | 18.18% | Needham | Ami Fadia55% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 18.18% | Needham | Ami Fadia55% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2024 | Buy Now | 19.09% | RBC Capital | Leonid Timashev37% | $130 → $131 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | -2.73% | Cantor Fitzgerald | Charles Duncan68% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | -2.73% | Cantor Fitzgerald | Charles Duncan68% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | Buy Now | -2.73% | Cantor Fitzgerald | Charles Duncan68% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | Buy Now | -2.73% | Cantor Fitzgerald | Charles Duncan68% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2024 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | 18.18% | Needham | Ami Fadia55% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | 27.27% | Wells Fargo | Cerena Chen30% | → $140 | Initiates | → Overweight | Get Alert |
| 08/22/2024 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 08/06/2024 | Buy Now | -4.55% | UBS | Ashwani Verma46% | $107 → $105 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | 18.18% | RBC Capital | Leonid Timashev37% | $131 → $130 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $190 → $180 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | -3.64% | B of A Securities | Jason Gerberry59% | $95 → $106 | Upgrade | Neutral → Buy | Get Alert |
| 08/06/2024 | Buy Now | 18.18% | Needham | Ami Fadia55% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | 18.18% | Needham | Ami Fadia55% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2024 | Buy Now | -2.73% | Cantor Fitzgerald | Charles Duncan68% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | 19.09% | RBC Capital | Leonid Timashev37% | $131 → $131 | Reiterates | Outperform → Outperform | Get Alert |
| 07/22/2024 | Buy Now | 18.18% | Needham | Ami Fadia55% | → $130 | Initiates | → Buy | Get Alert |
| 07/18/2024 | Buy Now | -13.64% | B of A Securities | Jason Gerberry59% | $97 → $95 | Maintains | Neutral | Get Alert |
| 06/12/2024 | Buy Now | -3.64% | Mizuho | Graig Suvannavejh51% | $106 → $106 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2024 | Buy Now | 72.73% | HC Wainwright & Co. | Raghuram Selvaraju42% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | 18.18% | RBC Capital | Leonid Timashev37% | $127 → $130 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | -3.64% | Mizuho | Graig Suvannavejh51% | $109 → $106 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 72.73% | HC Wainwright & Co. | Raghuram Selvaraju42% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 13.64% | Citigroup | David Hoang39% | $127 → $125 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 1.82% | Baird | Joel Beatty66% | $108 → $112 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | 4.55% | Morgan Stanley | Vikram Purohit37% | $90 → $115 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | -2.73% | Cantor Fitzgerald | Charles Duncan68% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 04/02/2024 | Buy Now | 72.73% | HC Wainwright & Co. | Raghuram Selvaraju42% | $190 → $190 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | -0.91% | Mizuho | Graig Suvannavejh51% | $108 → $109 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 36.36% | Truist Securities | Joon Lee76% | → $150 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 16.36% | RBC Capital | Leonid Timashev37% | $123 → $128 | Maintains | Outperform | Get Alert |
| 03/26/2024 | Buy Now | 15.45% | Citigroup | David Hoang39% | $125 → $127 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 72.73% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $190 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | -1.82% | Baird | Joel Beatty66% | → $108 | Initiates | → Outperform | Get Alert |
| 03/04/2024 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2024 | Buy Now | -1.82% | Mizuho | Graig Suvannavejh51% | $112 → $108 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | 13.64% | Guggenheim | Yatin Suneja49% | $110 → $125 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | 11.82% | RBC Capital | Leonid Timashev37% | $126 → $123 | Maintains | Outperform | Get Alert |
| 02/21/2024 | Buy Now | -6.36% | Cantor Fitzgerald | Charles Duncan68% | $108 → $103 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | -1.82% | Cantor Fitzgerald | Charles Duncan68% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | Buy Now | 1.82% | Mizuho | Graig Suvannavejh51% | $90 → $112 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | 0.91% | UBS | Ashwani Verma46% | → $111 | Initiates | → Buy | Get Alert |
| 01/25/2024 | Buy Now | 14.55% | RBC Capital | Leonid Timashev37% | → $126 | Initiates | → Outperform | Get Alert |
| 01/22/2024 | Buy Now | -1.82% | Cantor Fitzgerald | Charles Duncan68% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 01/16/2024 | Buy Now | 2.73% | Piper Sandler | David Amsellem72% | $90 → $113 | Maintains | Overweight | Get Alert |
| 12/26/2023 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | Buy Now | -1.82% | Cantor Fitzgerald | Charles Duncan68% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 12/13/2023 | Buy Now | 13.64% | Citigroup | David Hoang39% | → $125 | Initiates | → Buy | Get Alert |
| 12/12/2023 | Buy Now | 63.64% | HC Wainwright & Co. | Raghuram Selvaraju42% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | -1.82% | Cantor Fitzgerald | Charles Duncan68% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 09/25/2023 | Buy Now | -9.09% | Mizuho | Graig Suvannavejh51% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/28/2023 | Buy Now | -9.09% | Mizuho | Graig Suvannavejh51% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | Buy Now | -1.82% | Cantor Fitzgerald | Charles Duncan68% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
FAQ
What is the target price for Axsome Therapeutics (AXSM) stock?
The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by HC Wainwright & Co. on May 7, 2025. The analyst firm set a price target for $180.00 expecting AXSM to rise to within 12 months (a possible 63.64% upside). 67 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axsome Therapeutics (AXSM)?
The latest analyst rating for Axsome Therapeutics (NASDAQ:AXSM) was provided by HC Wainwright & Co., and Axsome Therapeutics maintained their buy rating.
When was the last upgrade for Axsome Therapeutics (AXSM)?
The last upgrade for Axsome Therapeutics Inc happened on August 6, 2024 when B of A Securities raised their price target to $106. B of A Securities previously had a neutral for Axsome Therapeutics Inc.
When was the last downgrade for Axsome Therapeutics (AXSM)?
There is no last downgrade for Axsome Therapeutics.
When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on May 7, 2025 so you should expect the next rating to be made available sometime around May 7, 2026.
Is the Analyst Rating Axsome Therapeutics (AXSM) correct?
While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a maintained with a price target of $200.00 to $180.00. The current price Axsome Therapeutics (AXSM) is trading at is $110.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
